North Run Capital’s Boston Scientific BSX Stock Holding History

North Run Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-248,000	Closed	-$3.17M	–	29
2014 Q2	$3.17M	Sell	248,000 -2,507,000	-91%	-$32.6M	0.31%	26
2014 Q1	$37.2M	Sell	2,755,000 -530,000	-16%	-$6.96M	3.79%	14
2013 Q4	$39.5M	Sell	3,285,000 -1,215,000	-27%	-$14.4M	5%	11
2013 Q3	$52.8M	Sell	4,500,000 -500,000	-10%	-$5.41M	6.88%	7
2013 Q2	$46.4M	Buy	+5,000,000	New	+$42.4M	5.38%	7

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

North Run Capital's BSX Position: Q3 2014 in Review

North Run Capital sold out of Boston Scientific (BSX) in Q3 2014, closing a stake of 248,000 shares — an estimated $3.17M sold.

North Run Capital first reported a position in BSX in Q2 2013 and held it in 5 quarters. The position peaked at $52.8M in Q3 2013. 437 funds tracked by Wall St. Rank hold BSX as of Q3 2014.

North Run Capital reported no remaining Boston Scientific position as of Q3 2014 after selling out during the quarter.
North Run Capital sold 248,000 Boston Scientific shares in Q3 2014, an estimated $3.17M.
North Run Capital first reported a position in Boston Scientific in Q2 2013 and held it in 5 quarters.
North Run Capital's Boston Scientific position peaked at $52.8M in Q3 2013.
437 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2014.

Based on North Run Capital's 13F filing for Q3 2014, filed 14 Nov 2014.